En Es
Categories

Industry News

Compact Devices Emerge As Segment of Ultrasound Market

By Medimaging International staff writers
09 Oct 2018

Image: The vScan handheld ultrasound device (Photo courtesy of GE Healthcare).The global ultrasound devices market was valued at USD 6.5 billion in 2017 and is projected to grow at a CAGR of 5.6% from 2018 to 2026 to reach USD 10.6 billion by 2026, as a surge in the incidence of disorders such as cardiovascular diseases, respiratory and abdominal disorders is likely to boost the demand for ultrasound devices.

These are the latest findings of Transparency Market Research, (Albany, NY, USA), a global market intelligence company providing business information reports and services.

Compact and/or handheld ultrasound devices are an emerging segment of the ultrasound devices market and are expected to register a significant growth during the forecast period. The segment is likely to hold a major market share due to technologically advanced products being adopted by diagnostic centers. In spite of the growing adoption of portable ultrasound devices for point-of-care applications, the trolley/cart based ultrasound devices segment will continue to grow at a comparatively faster pace, as these devices offer more accurate diagnostic capabilities and high performance.

Based on application, the radiology/general imaging segment is expected to be the most attractive due to increasing sophistication in diagnostic imaging platforms, allowing the emerging countries to provide 24x7 diagnostic services to the patient population. Based on end-user, the diagnostic centers segment held the largest share of the global ultrasound devices market in 2017, due to the availability of multiple service options and devices and tie-ups with health care companies with the aim of enhancing their health care products and service offerings. Additionally, diagnostic centers are highly preferred by the patient population owing to the availability of advanced technology and better health care services. The hospital & surgical centers segment is also growing at a fast pace, particularly in the developed economies, driven by an increase in geriatric population and growing health care infrastructure and support. Also, the increasing demand for ultrasound devices in ambulatory surgical centers during medical emergencies is expected to further aid the segment’s growth.

Geographically, Europe dominated the global ultrasound devices market in 2017 in terms of revenue with a value of USD 2.1 billion, due to the region’s highly developed health care sector, growing awareness about ultrasound devices among health care providers, and continuous evolution of ultrasound devices. The Asia Pacific ultrasound devices market is expected to grow at a CAGR of 6.2% during the forecast period, driven by increased awareness about ultrasound devices for diagnostic and therapeutic applications in the region. Additionally, the expansion of the health care sector in countries such as China, Japan, and India offers immense potential for the growth of the ultrasound devices market in this region. Moreover, technological advancements and increased adoption of ultrasound devices are expected to further drive the market growth in Asia Pacific during the forecast period.

Related Links:
Transparency Market Research



E-mail Print
FaceBook Twitter Google+ Linked in

Additional news

23 Nov 2018
AI Predicts Alzheimer’s Disease Years before Diagnosis
A new study on the application of deep learning (DL) to detect changes in brain metabolism predictive of Alzheimer’s disease (AD) has found that artificial intelligence (AI) improves the ability of brain imaging to predict AD.
Read More
23 Nov 2018
UK to Set Up New GBP 10 Million Centre for Medical Imaging and AI
The UK’s London Medical Imaging & Artificial Intelligence Centre for Value-Based Healthcare will train sophisticated artificial intelligence (AI) algorithms from NHS medical images and patient data, to create tools that will help clinicians speed up and improve diagnosis and care across a number of patient pathways, including dementia, heart failure and cancer.
Read More
23 Nov 2018
New AI Algorithm Enhances Polyp Detection in Colonoscopy Procedures
Researchers at Shanghai Wision AI Co., Ltd., a developer of computer-aided diagnostic algorithms and systems to improve the accuracy and effectiveness of diagnostic imaging, have announced results of a study validating a novel machine-learning algorithm that improves detection of adenomatous polyps during colonoscopy. The AI algorithm is built on the same network architecture that is used to develop self-driving cars and is designed to enable “self-driving” in colonoscopy procedures.
Read More
20 Nov 2018
Study Finds AI Falls Short When Analyzing Medical Data
A study conducted at the Icahn School of Medicine at Mount Sinai has found that artificial intelligence (AI) tools trained to detect pneumonia on chest X-rays suffered significant decreases in performance when tested on data from outside health systems. These findings suggest that unless AI in the medical space is carefully tested for performance across a wide range of populations, the deep learning models may not perform as accurately as expected.
Read More
20 Nov 2018
New AI Software for Brain Bleed Diagnosis Receives FDA Clearance
The US Food and Drug Administration (FDA) has given 510(k) clearance to the Accipio Ix intracranial hemorrhage (ICH) detection software developed by MaxQ AI, a clinical diagnostics intelligence platform company.
Read More
20 Nov 2018
Global Refurbished Medical Devices Market to Increase by 10% by 2023
The global refurbished medical devices market is expected to grow at a CAGR of over 10% during the forecast period 2019-2023, driven by the organized healthcare ecosystem in the developed economies. Moreover, privatization in the healthcare sector is increasing rapidly due to the inability of governments to invest efficiently in the sector, coupled with high demand for innovation and technology for superior healthcare services.
Read More
12 Nov 2018
ACR Data Science Institute Releases AI Use Cases to Accelerate AI Adoption
The American College of Radiology Data Science Institute has released a first-of-its-kind series of standardized artificial intelligence (AI) use cases that will accelerate medical imaging AI adoption. This continually updated, freely available use case series is the product of a previously missing and collaborative framework that enables efficient creation, implementation and ongoing improvement of radiological AI tools.
Read More
12 Nov 2018
Siemens Healthineers and Primary Health Care Enter Contract for In Vitro Diagnostics
Siemens Healthineers has entered into a strategic partnership with Australian integrated healthcare provider Primary Health Care to deploy more than 70 Atellica Solution immunoassay and clinical chemistry analyzers, marking the largest contract ever for in vitro diagnostics testing in the country.
Read More
12 Nov 2018
OpenSight Augmented Reality System for Microsoft HoloLens Cleared by FDA
The FDA has granted 510(k) clearance to the OpenSight Augmented Reality System, making it the first AR medical solution for Microsoft HoloLens to be cleared for use in pre-operative surgical planning. Developed by Novarad, a provider of specialized enterprise imaging and workflow solutions, OpenSight renders 2D, 3D and 4D images of patients interactively, while accurately overlaying them directly onto the patient’s body.
Read More
Copyright © 2000-2018 TradeMed.com. All rights reserved. | Terms And Conditions